These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17294060)

  • 1. [Induction therapy with corticoid pulses for treatment of temporal arteritis].
    Krüger K
    Z Rheumatol; 2007 Mar; 66(2):165-6. PubMed ID: 17294060
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of high-dose intravenous methylprednisolone as induction therapy for giant cell arteritis: comment on the article by Mazlumzadeh et al.
    Arashvand K
    Arthritis Rheum; 2007 May; 56(5):1722; author reply 1723-4. PubMed ID: 17469170
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-complicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent. Evaluation of 15 patients].
    Sailler L; Carreiro M; Ollier S; Juchet H; Delobel P; Ferrand D; Klinger M; Arlet P
    Rev Med Interne; 2001 Nov; 22(11):1032-8. PubMed ID: 11817115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?
    Teshima C; Fedorak RN
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S216-8. PubMed ID: 18816775
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.
    Hwang JM; Girkin CA; Perry JD; Lai JC; Miller NR; Hellmann DB
    Am J Ophthalmol; 1999 Jan; 127(1):102-4. PubMed ID: 9933015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of pulse corticosteroid therapy for juvenile dermatomyositis.
    Paller AS
    Pediatr Dermatol; 1996; 13(4):347-8. PubMed ID: 8844758
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].
    Juchet H; Arlet P; Ollier S; Montané de la Roque P; Le Tallec Y
    Ann Med Interne (Paris); 1992; 143(2):85-8. PubMed ID: 1530225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
    Bertoli AM; Font YM; Nadal A; Vilá LM
    Arthritis Rheum; 2007 May; 56(5):1723; author reply 1723-4. PubMed ID: 17469171
    [No Abstract]   [Full Text] [Related]  

  • 11. Embouchure Claudication: A Trumpeter's Unique Presentation of Giant Cell Arteritis.
    Chenevey RE; Afkhamnejad ER; Martin TJ
    J Neuroophthalmol; 2019 Dec; 39(4):498-499. PubMed ID: 31790373
    [No Abstract]   [Full Text] [Related]  

  • 12. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
    Jover JA; Hernández-Garcia C; Morado IC; Vargas E; Bañares A; Fernandez-Gutierrez B
    Arthritis Rheum; 2003 Apr; 48(4):1158-9. PubMed ID: 12687561
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance imaging in optic neuritis due to giant cell arteritis.
    Garcia-Porrua C; Santamarina R; Armesto V; Gonzalez-Gay MA
    Arthritis Rheum; 2005 Apr; 53(2):313-4. PubMed ID: 15818643
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial of Tocilizumab in Giant-Cell Arteritis.
    Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Schett G; Schulze-Koops H; Spiera R; Unizony SH; Collinson N
    N Engl J Med; 2017 Jul; 377(4):317-328. PubMed ID: 28745999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
    Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B
    Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of medium-dose prednisone in giant cell arteritis: a retrospective cohort study of 103 patients.
    Les I; Pijoán JI; Rodríguez-Álvarez R; Ruiz-Irastorza G; Martínez-Berriotxoa A
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-90-7. PubMed ID: 26016756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
    Spiera RF; Kupersmith M; Paget S; Spiera H
    Arthritis Rheum; 2003 Apr; 48(4):1159-60; author reply 1160-1. PubMed ID: 12687562
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial.
    Li Y; Fu R; Gao J; Wang L; Duan Z; Tian L; Ge H; Ma X; Zhang Y; Li K; Xu P; Tian X; Chen Z
    Sci Rep; 2022 Jan; 12(1):255. PubMed ID: 34996948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
    Chevalet P; Barrier JH; Pottier P; Magadur-Joly G; Pottier MA; Hamidou M; Planchon B; El Kouri D; Connan L; Dupond JL; De Wazieres B; Dien G; Duhamel E; Grosbois B; Jego P; Le Strat A; Capdeville J; Letellier P; Agron L
    J Rheumatol; 2000 Jun; 27(6):1484-91. PubMed ID: 10852275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient visual loss due to reversible 'pending' central retinal artery occlusion in occult giant cell arteritis.
    Sane M; Selvadurai A; Reidy J; Higgs D; Gonzalez-Fernandez F; Lincoff N
    Eye (Lond); 2014 Nov; 28(11):1387-90. PubMed ID: 25081291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.